PALLADONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Palladone, and what generic alternatives are available?
Palladone is a drug marketed by Purdue Pharma Lp and is included in one NDA.
The generic ingredient in PALLADONE is hydromorphone hydrochloride. There are fourteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the hydromorphone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Palladone
A generic version of PALLADONE was approved as hydromorphone hydrochloride by HIKMA on July 29th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PALLADONE?
- What are the global sales for PALLADONE?
- What is Average Wholesale Price for PALLADONE?
Summary for PALLADONE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 1 |
Patent Applications: | 5,827 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PALLADONE |
DailyMed Link: | PALLADONE at DailyMed |
Recent Clinical Trials for PALLADONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Miami | Phase 2 |
US Patents and Regulatory Information for PALLADONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-001 | Sep 24, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-004 | Sep 24, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-002 | Sep 24, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-003 | Sep 24, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PALLADONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-001 | Sep 24, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-004 | Sep 24, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-004 | Sep 24, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | PALLADONE | hydromorphone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021044-002 | Sep 24, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PALLADONE
See the table below for patents covering PALLADONE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 660512 | ⤷ Sign Up | |
Japan | H07145056 | OPIOID PREPARATION HAVING EXTENDED RELEASE INHIBITING PROPERTIES | ⤷ Sign Up |
Taiwan | 496736 | ⤷ Sign Up | |
Australia | 704524 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |